Reta is an investigational weight-loss 🌶 currently in Phase 3 clinical trials, with FDA approval not expected until 2026 or later. It is not yet available for prescription, with projected monthly costs estimated between $1,000 and $1,500 based on similar drugs like Zepbound. Currently, legal access is primarily through official clinical trials.Â